Benzinga | Jul 29, 2020 09:35AM EDT

Raymond James Maintains Outperform on DexCom, Raises Price Target to $450

Raymond James maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $395 to $450.